SUMMARY The prognosis of ulcerative colitis including survival, colectomy rate, activity of disease, and working capacity was estimated from a follow up study of 783 patients with ulcerative colitis comprising all patients from the county of Copenhagen, except for the island of Amager, diagnosed between 1960 and 1978. The period of observation ranged from one to 18 years with a median of 6-7 years for the clinical observations, eight years for survival and 11.6 years for the occurrence of large bowel cancer. The follow up was 100% for both survival and cancer. The survival rate in women did not differ from that in the general population. In men over 40 years of age at diagnosis a slight excess mortality was found, but only in the year of diagnosis (2 1%) and the following year (1.5%). Colonic cancer was seen in only seven out of the 783 patients, corresponding to an annual risk of 0'07% and a cumulative risk after 18 years with ulcerative colitis of 1-4% (95% confidence limits, 0 7-2-8%) independent of the initial extent of disease. The colectomy rate was 9-6% in the year of diagnosis. The cumulative 10-and 18-year colectomy rate was 23% and 31%, respectively. After three years from diagnosis the capacity for work both in those subject to resection and treated conservatively did not differ significantly from that in the background population. At any time about 50% of the patients were without symptoms, in about 30% the disease activity was low and in about 20% moderate or high. Most patients, however, differed in activity from one year to another and almost all patients (97%) experienced at least one relapse during a 10 year time period.
'T'he impact of a chronic disease on the life of the individual depends on three major factors: the premorbid state of the patient (age, intellectual condition, physical condition, etc), the course of the disease (intermittent or continuous, high or moderate activity, etc), and the efficacy and type of treatment. These factors combined determine the prognosis of the disease in terms of survival as well as in measurement of the quality of life.
The aim of the present study was to evaluate the prognosis of ulcerative colitis on the basis of survival, working capacity, colectomy rate, activity and course of disease, and thereby attempt to answer the inevitable question from the newly diagnosed patient: ' The capacity for work was defined by the days lost through sickness, independent of cause. Fully capable: less than one month lost through sickness during the year. Partly capable: one month or more but less than 11 months lost through sickness during the year. Not capable: 11 months or more lost through sickness during the year.
STATISTICAL METHODS
The risk of death was finally compared with the mortality of the population at large. For each year after diagnosis, the expected number of deaths among the patients at risk was estimated taking into account for each individual both sex, age, and calendar year. The difference between the observed and the expected number of deaths was evaluated on the assumption that the actual number of deaths is distributed according to a Poisson distribution.
Results

SURVIVAL RATES
Patients with ulcerative colitis are shown in Figs. 1 and 2 together with their survival rates of the age-matched background population. In the women the survival did not differ between the patients and the background population at any time. The men had a slightly increased mortality in the year of diagnosis (2-1%) and the following year (1.5%).
From the second year after diagnosis the survival did not differ from that of the background population. The extra mortality in the first and the second disease year was only significant in age groups over 40 years at diagnosis. (Fig. 3) . Ten per cent of the patients had an operation in the year of diagnosis and 3% in the following year. After four years the risk of undergoing colectomy was constant, about 1% per year. In Figure 4 the cumulative colectomy rates are given. A total of 149 patients underwent colectomy during the observation period.
ACTIVITY OF DISEASE
This was estimated for each separate year after diagnosis (Fig. 5) . At any time about 50% of the patients were free of symptoms. The percentage was increased slightly with increasing duration of the disease. Similarly, in about 30% the disease was at any time in low activity and in about 20% in moderate or high activity. Most patients, however, differ in activity from one year to another. The chance of being free of relapses is seen in Figure 6 . After 10 years less than 3% and after 18 years less than 1% of the patients had not experienced a relapse. Figure 7 for each year after diagnosis. About 10% of the patients had a continuous and about 40% an intermittent course. This calculation was based upon unoperated patients only, but included patient years up to the time of operation. A continuous course over several years was rare, and the cumulative probability of such a course is shown in Table 2 . The percentage of patients with persistent symptoms fell rapidly during the first few years and was almost zero after 10 years because many of this group underwent colectomy.
WORKING CAPACITY
This was estimated for all patients in their employable age, shown in Figure 8 , for each year after diagnosis. Except for the first few years, about 90% of the patients were fully capable of work. Less than 5% received disablement pension and practically none of them because of their inflammatory bowel disease.
Discussion
We have previously shown that our patient group Ulcerative colitis Cumulative relapse-free course area. The analyses revealed a stationary course from the fifth year from diagnosis onwards. An analysis was made of the clinical disease activity and course of disease in the year before drop out for those patients who were lost because of emigration from the district or who failed to attend for personal reasons. The analysis showed no difference in the disease activity and course between these patients and those remaining in the study. Thus it seems that the remaining patient group was not skewed.
The excellent overall prognosis of ulcerative colitis in this study confirms results previously published from our group for the period 1960-1971,3 and our cancer risk figures are similar to those recorded from Israel.4 Other studies,>'0 however, have shown a more serious prognosis with a higher mortality and a higher cancer risk. The regional and thereby unselected patient group in our study tends to show the true picture of the disease and a better prognosis than in a group of patients selected for severity. Further patients in this study were treated by a specialist group from onset which presumably will lead to a better prognosis. The therapeutic approach has been active -that is, the patients have been controlled regularly in the outpatient clinic and with rapid admission to hospital in the case of relapse.
The possibility that ulcerative colitis may take a less serious course in Denmark seems unlikely, because about 30% of the patients underwent colectomy within the first 18 years. Among the patients treated by colectomy the largest part comprises patients with initial total colon involvement. Since it is known that patients with extensive colitis are at risk for cancer, our therapeutic policy in the first years after diagnosis has reduced the number of patients at risk. Leeds"' and London.12 The finding that 90% of the patients were fully capable for work is similar to that in the background population, even if a directly comparable registration of absence from work is not available. In 1981 4.4% of the Danish population between 14 and 66 years received disablement pension,'3 a figure which does not differ from that found in our ulcerative colitis patients. These results on social prognosis are in agreement with a previous study which compared a randomised group of ulcerative colitis patients with an age-and sexmatched control group. 14 The two groups were similar in marital status, the frequency of severe family or sexual problems, leisure activities, physical capacity and earning capacity, the incidence of mental disorders, and intake of alcohol and psychopharmacological drugs.
A very recent study from Scotland'5 showed a good prognosis in ulcerative colitis as in the present study with an improving course as the duration of the disease increased. The reported incidence of ulcerative colitis in Scotland is much higher than our own study.
Ulcerative colitis has a chronic course, and the inconveniences for operated as well as unoperated patients should not be minimised. It however, appears that with an active therapeutic approach the patients seem to lead a near normal life. 
